1-5 of 5
Esther H. Lips
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial

Philip C. Schouten, Lisa Richters, Daniel J. Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roelof J.C. Kluin, Frederik Marmé, Esther H. Lips, Sandra Schmidt, Esther Scheerman, Katharina Prieske, Carolien H.M. van Deurzen, Alexander Burges, Patricia C. Ewing-Graham, Dimo Dietrich, Agnes Jager, Nikolaus de Gregorio, Jan Hauke, Andreas du Bois, Petra M. Nederlof, Lodewyk F. Wessels, Eric Hahnen, Philipp Harter, Sabine C. Linn, Rita K. Schmutzler
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6559–6569.
https://doi.org/10.1158/1078-0432.CCR-21-1673
Published: 01 December 2021
View articletitled, Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial
Open the PDF for Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial in another window
Includes: Supplementary data
Journal Articles

Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore

Tessa G. Steenbruggen, Maartje van Seijen, Liselore M. Janssen, Mette S. van Ramshorst, Erik van Werkhoven, Marie-Jeanne T.D.F. Vrancken Peeters, Jelle Wesseling, Esther H. Lips, Gabe S. Sonke
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4985–4992.
https://doi.org/10.1158/1078-0432.CCR-19-0560
Published: 15 August 2019
View articletitled, Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore
Open the PDF for Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore in another window
Includes: Supplementary data
Journal Articles

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ—A Nested Case–Control Study

Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld, Koen van de Vijver, Emma J. Groen, Mathilde M. Almekinders, Carolien Bierman, Flora E. van Leeuwen, Emiel J. Rutgers, Marjanka K. Schmidt, Esther H. Lips, Jelle Wesseling
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (15): 3593–3601.
https://doi.org/10.1158/1078-0432.CCR-18-0201
Published: 31 July 2018
View articletitled, Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ—A Nested Case–Control Study
Open the PDF for Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ—A Nested Case–Control Study in another window
Includes: Supplementary data
Journal Articles

BRCA1-Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency

Esther H. Lips, Rashmie D. Debipersad, Caroline E. Scheerman, Lennart Mulder, Gabe S. Sonke, Lizet E. van der Kolk, Jelle Wesseling, Frans B.L. Hogervorst, Petra M. Nederlof
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1236–1241.
https://doi.org/10.1158/1078-0432.CCR-16-0198
Published: 28 February 2017
View articletitled, BRCA1-Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
Open the PDF for BRCA1-Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency in another window
Includes: Supplementary data
Journal Articles

Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer

Esther H. Lips, Ronald van Eijk, Eelco J.R. de Graaf, Pascal G. Doornebosch, Noel F.C.C. de Miranda, Jan Oosting, Tom Karsten, Paul H.C. Eilers, Rob A.E.M. Tollenaar, Tom van Wezel, Hans Morreau
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 772–781.
https://doi.org/10.1158/1078-0432.CCR-07-2052
Published: 01 February 2008
View articletitled, Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer
Open the PDF for Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer in another window
Includes: Supplementary data